Hosted on MSN10d
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
That will include providing drug samples to health-care providers. Eli Lilly is also investing heavily in its ...
The Motley Fool on MSN2d
Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock.
Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...
BizTimes2d
Eli Lilly buys another 31 acres in Kenosha County
Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the ...
Why Eli Lilly Is a No-Brainer Stock to Buy on the Dip
Even with this partial rebound, Lilly's share price remains roughly 13% below the peak set in late August. Some investors ...
The Tokenist11d
Eli Lilly & Co. Reports Third Quarter with $1.18 EPS, Downgrades Guidance
Eli Lilly & Co. reported its results for the third quarter of 2024, with revenue up 20% y/y but failing to meet market ...
BizTimes6d
Eli Lilly buys another Kenosha County building, for $40 million
Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased a 323,930-square-foot industrial building in the ...
NBC New York10d
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
Eli Lilly is also investing heavily in its direct-to-consumer website, which offers telehealth prescriptions and direct home delivery of certain drugs to expand patient access, executives said ...